Since both decreased insulin and increased glucagon secretion from pancreatic islets are known to contribute to hyperglycemia in patients with T2D [49], we investigated whether the identified candidate genes also affect glucagon secretion in clonal α-cells. The gene discussed is INS; the disease is Hyperglycemia.